Loading quotes...

Forecast

Buy
  4
Hold
  1
Sell
  1

Discussions in the community

  • Translated from German

    Looking forward to your thoughts! I've been torn between ETFs and individual stocks for a long time…

    Simon Simon I in Portfolio Roasts

    2 19
  • Translated from German

    2-Year-Old Portfolio (Employed, 22 Years Old)

    Luca S. Luca S. I in Portfolio Roasts

    7 2
  • Translated from German

    Stefan buys stocks

    S Stefan V in Portfolio Roasts

    13 32
  • Translated from German

    Opinion / Suggestions for Improvement

    J Justin IV in Portfolio Roasts

    0 7
  • Translated from German

    Portfolio

    M0 Marie.mar 03 V in Portfolio Roasts

    6 23

  • Antitrust case against Brau Union (Heineken) referred to the European Court of Justice

    The antitrust proceedings by the Austrian Federal Competition Authority (BWB) against Brau Union, part of the Heineken group, over alleged abuse of market power have been referred to the European Court of Justice. The BWB accuses the group of pressuring beverage retailers to prioritise selling its products. Heineken denies the allegations and complains of insufficient access to the case files; if convicted the company could face a fine of up to ten percent of group turnover. An ECJ decision can take more than a year, and the ongoing proceedings before the Cartel Court in Vienna remain unaffected. » More on kurier.at


  • Heineken beats expectations thanks to premium and non-alcoholic beer

    Heineken reports an organic volume increase of 4.8% in the third quarter and a sales rise of 4.6%, well above analysts' expectations of 2.9% and 3.5% respectively. The premium segment grew particularly strongly, by 11.5%; all regions contributed to the growth. New group CEO Rafa Oliveira is calling for a stronger performance culture and faster execution and plans to present details of his strategy in February. For the full year 2026, Heineken confirms its forecast of organic operating profit growth of 2% to 6%. » More on n-tv.de


  • Heineken warns of sales risk in British pubs from weight-loss injections

    Heineken warns that GLP-1 weight-loss drugs such as Ozempic or Wegovy could reduce alcohol cravings through increased feelings of fullness, endangering beer and cider sales in British pubs. The company recommended measures for publicans such as smaller beer glasses, alcohol-free alternatives and food pairings to cushion revenue losses. U.S. market data show households with GLP-1 users have about 7% lower alcohol spending after two years and roughly 13.5% less spending on beer; other spirits companies so far assess the risk as manageable. » More on manager-magazin.de


  • Heineken warns GLP-1 weight-loss drugs could dent UK beer and cider sales

    Heineken told UK pub and bar customers that the rise of GLP-1 drugs such as Wegovy and Ozempic can reduce desire to drink alcohol, leading to smaller serves and fewer pints per visit. The brewer advised promoting half-pints, low- and no-alcohol options and food pairings to mitigate potential declines in visits and spending. Heineken said it will monitor changing consumption patterns through 2027, while industry data on the impact remains mixed. » More on theguardian.com


  • Heineken ordered to pay €111 million in damages, group announces appeal

    A Dutch court has ordered Heineken to pay €111 million in a dispute between its Greek subsidiary Athenian Brewery and rival Macedonian Thrace Brewery (€43m in damages plus €68m in interest). Heineken plans to appeal, saying the underlying assumptions on sales, pricing and profitability are unrealistic. The case concerns the subsidiary’s conduct between 1998 and 2014; in 2015 Athenian Brewery was already fined by the Greek competition authority. » More on t-online.de

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Heineken has already paid €1.92 in dividends. The last payout was in August.

Financials

In the last quarter, Heineken had revenue of €14.84B and net profit of €1.13B
(EUR) June 2026
YoY
Revenue 14.84B -
Gross profit 1.61B -
Net profit 1.13B -
EBITDA 2.81B -

Fundamentals

Metric Value
Market capitalization
€46.8B
Number of shares
552.38M
52-week high/low
€84.80 - €63.90
Dividend yield
2.27%
Dividends TTM
€1.92
Beta
0.52
P/E ratio
20.71
PEG ratio
0.35
P/B ratio
2.43
P/S ratio
1.28

Company profile

Heineken N.V. engages in the brewing and selling of beer and cider. It also provides soft drinks and water. It offers its beers under the Heineken, Amstel, Desperados, Sol, Tiger, Birra Moretti, Affligem, Lagunitas, and Mort Subite brands, as well as under various other regional and local brands; and cider under the Strongbow Apple Ciders, Orchard Thieves, Follow The Fox, Cidrerie Stassen, Bulmers, Old Mout, and Blind Pig brands. The company offers its products to retailers, bars, pubs, hotels, and restaurants in Europe, Americas, Africa, the Middle East, Eastern Europe, and the Asia Pacific markets. The company was founded in 1864 and is based in Amsterdam, the Netherlands. Heineken N.V. is a subsidiary of Heineken Holding N.V.

Name
Heineken
CEO
Rafa de Oliveira
Headquarters Amsterdam, nh
Netherlands
Website
Sector
Consumer Staples
Industry
Beverages
IPO
03/29/1995
Employees 85,000

Ticker symbols

Exchange Symbol
XETRA
HNK1.DE
Pnk
HINKF
Euronext
HEIA.AS
SIX
HEI.SW
Amsterdam
HEIA.AS
Frankfurt
HNK1.F
Düsseldorf
HNK1.DU
Hamburg
HNK1.HM
London
0O26.L
München
HNK1.MU
Wien
HEIA.VI
🍪

Parqet  uses cookies. Learn more